Methylation-enhanced ALK fusion detection
finds 31% more patients – beyond DNA alone1
Similar to how RNA profiling improves fusion detection in tissue,
epigenomics does the same in liquid — overcoming DNA-only CGP testing limitations2
epigenomics does the same in liquid — overcoming DNA-only CGP testing limitations2
ALK fusion patients detected by Guardant360 Liquid CDx Test
Guardant360 Liquid CDx ALK Fusion Detection1
+31%
more patients
Detected all ALK fusions identified by
genomics
genomics
through
methylation-enhanced
detection
methylation-enhanced
detection
Find more ALK fusion patients with the
only liquid biopsy with epigenomics1,3–6
only liquid biopsy with epigenomics1,3–6
Home Oncology Portfolio Partnerships European Policy